Several commonly encountered clinical conditions are associated with changes in neurohumoral influences of the heart and coronary vessels. Adrenergic supersensitivity of coronary vessels may result following chronic cardiac denervation or following alterations of neurotransmitter disposition. These conditions may augment coronary constriction to either endogenous or exogenous catecholamines and may thus significantly alter myocardial perfusion under conditions of stress and adrenergic stimulation. One goal of these studies will be to determine if coronary alpha and beta adrenergic sensitivity is regulated principally by circulating or neuronal catecholamines or if there is redundant control, i.e. regulation by both circulating and neuronal norepinephrine. Responses of both large and small coronary vessels will be examined in vitro and selected experiments will be performed on coronary microvessels in vivo. Unique applications of autoradiographic ligand binding studies will be performed to determine if either beta (large and small vessels) or alpha 2 (small vessels) adrenergic receptor number of affinity is altered by either chronic sympathectomy or depletion of circulating norepinephrine. A second goal will be to determine if following sympathectomy there is an augmentation of extraneural metabolism of norepinephrine beyond that observed following acute inhibition of neuronal uptake of norepinephrine. Augmentation of extraneuronal norepinephrine metabolism would prevent the development of prejunctional supersensitivity following sympathectomy. The third goal of these studies will be to determine if changes in the disposition of norepinephrine can produce adrenergic supersensitivity in either small or large coronary vessels. In these experiments both in vitro and in vivo methodology will be employed. These studies will employ a variety of unique in vivo and in vitro approaches which should provide important new information regarding the regulation of adrenergic sensitivity and neuroeffector mechanisms in coronary vascular smooth muscle.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039006-02
Application #
3355519
Study Section
Cardiovascular and Pulmonary Research B Study Section (CVB)
Project Start
1987-08-01
Project End
1990-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Loperena, Roxana; Van Beusecum, Justin P; Itani, Hana A et al. (2018) Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide. Cardiovasc Res 114:1547-1563
Norlander, Allison E; Madhur, Meena S; Harrison, David G (2018) The immunology of hypertension. J Exp Med 215:21-33
Tran, Anh Nhat; Walker, Kiera; Harrison, David G et al. (2018) Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Neuro Oncol 20:1055-1067
Pandey, Arvind K; Singhi, Eric K; Arroyo, Juan Pablo et al. (2018) Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Hypertension 71:e1-e8
Bersi, M R; Khosravi, R; Wujciak, A J et al. (2017) Differential cell-matrix mechanoadaptations and inflammation drive regional propensities to aortic fibrosis, aneurysm or dissection in hypertension. J R Soc Interface 14:
Norlander, Allison E; Saleh, Mohamed A; Pandey, Arvind K et al. (2017) A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage. JCI Insight 2:
Barbaro, Natalia R; Foss, Jason D; Kryshtal, Dmytro O et al. (2017) Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension. Cell Rep 21:1009-1020
Watanabe, Ryu; Shirai, Tsuyoshi; Namkoong, Hong et al. (2017) Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest 127:2725-2738
Barbaro, Natalia R; Kirabo, Annet; Harrison, David G (2017) A New Role of Mister (MR) T in Hypertension: Mineralocorticoid Receptor, Immune System, and Hypertension. Circ Res 120:1527-1529
Dikalova, Anna E; Itani, Hana A; Nazarewicz, Rafal R et al. (2017) Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension. Circ Res 121:564-574

Showing the most recent 10 out of 141 publications